Avinger Inc. (AVGR): ערך חשבונאי של החברה

Avinger, Inc. (AVGR) operational efficiency relies on the precise delivery of vascular surgery tools, which minimizes hospital inventory costs. The business develops OCT-navigation systems, including the Pantheris catheter, which prevents arterial damage during plaque removal. Current revenue is based on the sale of atherectomy devices, reaching 0.00, while new approvals are pending. This chart illustrates the price action for AVGR.

The metric is calculated as the product of the number of shares and the value of net assets, determining the intrinsic value of the business and protecting the investor from overpaying for market optimism. For Avinger, Inc. (AVGR), whose expansion rates are limited by FDA regulations, the level of the company's balance sheet capital serves as an indicator of the real stability of the optical catheter ecosystem amid the slow renewal of equipment fleets in clinics.